CBIO
Crescent Biopharma, Inc.
13.90$
-2.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -45.5% | -37.2% | -15.0% | -34.5% | +432,058.7% | -100.0% | – | +1,300.0% | +92.9% | +18.5% | +3.1% | – | |
| – | +6.4% | +30.0% | +1.5% | -8.7% | +1.9% | +5.9% | +334.5% | -62.8% | +138.9% | -13.3% | -3.6% | – | |
| – | – | -495.0% | – | – | +1,207.9% | +28.2% | -170.5% | – | -487.8% | – | -70.1% | – | |
| – | -89.8% | +828.7% | -65.9% | -99.9% | +100.0% | -100.0% | – | +318.6% | +12,219.6% | -88.7% | -99.8% | – | |
| – | -89.8% | +828.7% | -65.9% | – | +200.8% | – | – | +318.6% | +12,219.6% | -88.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -98.4% | +390.3% | -89.8% | -1,179.6% | – | -103.6% | – | -100.9% | – | -103.9% | – | – | |
| – | – | – | – | – | – | – | – | -114.9% | – | -130.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.